Copyright
©The Author(s) 2020.
World J Gastrointest Pharmacol Ther. Nov 8, 2020; 11(5): 93-109
Published online Nov 8, 2020. doi: 10.4292/wjgpt.v11.i5.93
Published online Nov 8, 2020. doi: 10.4292/wjgpt.v11.i5.93
Figure 2 At 7 d or 14 d post-injury, we assessed the adhesion score (0-4), min/med/max.
Medication (/kg, 1 mL bath/rat) at abdominal cavity was BPC 157 (10 µg) (B), L-arginine (A) (100 mg), L-NAME (5 mg) alone or in combinations (L-NAME + L-arginine (NA), L-arginine + BPC 157 (AB), L-NAME + BPC 157 (NB), L-arginine + L-NAME + BPC 157 (ANB) or saline bath equal volume (controls) (C). aP < 0.05 at least vs control; BPC 10 ng presented adhesion score 1/1/1 with L-arginine (L-arginine + BPC 157); Score 1/1/1 with L-NAME (L-NAME + BPC 157); Score 1/1/1 with L-arginine and L-NAME (L-arginine + L-NAME + BPC 157), aP < 0.05 at least vs control.
- Citation: Berkopic Cesar L, Gojkovic S, Krezic I, Malekinusic D, Zizek H, Batelja Vuletic L, Petrovic A, Horvat Pavlov K, Drmic D, Kokot A, Vlainic J, Seiwerth S, Sikiric P. Bowel adhesion and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine in rats. World J Gastrointest Pharmacol Ther 2020; 11(5): 93-109
- URL: https://www.wjgnet.com/2150-5349/full/v11/i5/93.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v11.i5.93